Details
Webinar Abstract
Illumina’s BaseSpace Sequence Hub (BSSH) supports primary and secondary analysis of massively parallel sequencing data and can be applied to gene panel data that is generated as part of a clinical cancer assay performed in a pathology lab.
In this webinar, Lynn Fink of Xing Cancer Care will discuss how her ISO15189-accredited lab has used BSSH to support informatics data analysis as part of its routine testing and will share details of why the lab chose this platform over other options.
In particular, Lynn will share how the lab uses the BSSH-hosted DRAGEN (Dynamic Read Analysis for Genomics) apps — Enrichment, Germline, and Somatic — to perform in-depth coverage analyses of a 1,000 cancer gene panel, germline alteration calling, and tumor-normal paired somatic alteration calling, respectively. These apps support about 95 percent of the lab’s analytical needs.
Webinar Speaker
Lynn Fink
Laboratory Director, Xing Cancer Care, Australia
Fill Out Form to Access Webinar
Your email address is never shared with third parties.
- Date & Time
- 29 Oct. 2020
- Available On-Demand
- Location
- Australia
- South APAC
- Affiliation
- Xing Cancer Care, Australia
- Presenter
- Lynn Fink, Laboratory Director
- Topic
- Software & informatics, Cancer research